Gland Pharma Q3 Results FY2024

Date: 14-Feb-2024

Gland Pharma Q3 FY2024 Revenue from Operations

Revenue from operations

Q3-FY24

% Change

₹1,545.15

Q2-FY24 

Q3-FY23

₹1,373.42

₹938.28

(Current)

(Q-o-Q)

(Y-o-Y)

12.50%

64.68%

Gland Pharma Q3 FY2024 EBIT

EBIT (Cr)

Q3-FY24

% Change

₹283.15

Q2-FY24

Q3-FY23 

₹289.88

₹310.85

(Current)

(Q-o-Q)

(Y-o-Y)

-2.32%

-8.91%

Gland Pharma Q3 FY2024 EBIT MARGIN

EBIT M (%)

Q3-FY24

% Change

18.33%

Q2-FY24

Q3-FY23 

21.11%

33.13%

(Current)

(Q-o-Q)

(Y-o-Y)

-2.78 BPS

-14.80 BPS

Gland Pharma Q3 FY2024 PAT

PAT (Cr)

Q3-FY24

% Change

₹191.85

Q2-FY24

Q3-FY23

₹194.08

₹231.94

(Current)

(Q-o-Q)

(Y-o-Y)

-1.15%

-17.28%

Gland Pharma Q3 FY2024 PAT MARGIN

PAT M (%)

Q3-FY24

% Change

12.42%

Q2-FY24

Q3-FY23

14.13%

24.72%

(Current)

(Q-o-Q)

(Y-o-Y)

-1.71 BPS

-12.30 BPS

Gland Pharma Q3 FY2024 BASIC EPS

BASIC EPS

Q3-FY24

% Change

11.65

Q2-FY24

Q3-FY23

11.78

14.08

(Current)

(Q-o-Q)

(Y-o-Y)

-1.10%

-17.26%

Swipe up to

Arrow